Miller Lab logo

University of Washington   |   Department of Pediatrics   |   Department of Laboratory Medicine & Pathology

Around 50% of individuals with a suspected genetic disorder remain undiagnosed after a complete clinical evaluation, which often takes years to complete. We believe this burden on patients and families is simply too high. In the Miller Lab, our goals are threefold: to improve the efficiency and effectiveness of genetic testing, to promote equity in genetic testing by reducing barriers to receiving a comprehensive genetic evaluation, and to better understand human genetic disease through the identification and characterization of novel disease-causing variation.




Danny Miller, MD, PhD

Principal Investigator

email  github twitter linkedin bluesky

Zach Anderson

Undergraduate Research Assistant


Nikhita Damaraju, MS

PhD Student, Public Health Genetics


Sophie Gibson

PhD Student, Genome Sciences


Joy Goffena, MS

Lab Manager


Pankhuri Gupta

Research Genetic Counselor


J. (Gus) Gustafson

PhD Student, Molecular & Cellular Biology


Kelsey Kanavel

Master's Student, Genetic Epidemiology


Bernhard Kayser, PhD

Visiting Scientist


Angie Miller

Research Coordinator


Maisha Sinha

Undergraduate Research Assistant

Sophie S

Sophie Storz

Research Scientist


Sydney Ward

Research Scientist


Jianing Xu, VMD

Veterinary Resident


Sunny Ye

Master's Student, Laboratory Medicine


Miranda PG Zalusky, MS

Computational Biologist


DNA image


Unsolved genetic disorders

We are interested in understanding why 50% of individuals with a suspected genetic disorder remain unsolved after a complete clinical evaluation. Using long-read DNA and RNA sequencing, we identify disease-causing variants that would be difficult or impossible to resolve using standard clinical testing. We are always happy to collaborate, so reach out if you have a challenging unsolved case.

Clinical applications of long-read sequencing

Standard clinical genetic testing can take years to complete and is diagnostic only 50% of the time. It's a challenging process often referred to as the diagnostic odyssey. We are working to change this paradigm by using long-read sequencing as a single test in the clinical setting. Our efforts extend beyond the genetics clinic into spaces such as cancer biology and infectious disease.

Structural variation

A major challenge when analyzing long-read sequencing data is interpreting all of the structural variants that are found. In collaboration with Oxford Nanopore, we are sequencing a large number of 1000 Genomes Project samples to understand what normal human structural variation looks like and to build a database of controls for everyone to use. Check out the 1000G ONT Sequencing Consortium site for more information.


Because long-read sequencing data contain signal for both the DNA sequence and methylation status, we can identify differences in methylation in unsolved cases and healthy controls. We are building tools to identify differences in methylation genome-wide and understand what methylation looks like in a large number of healthy controls.

Genome assembly and analysis

This is how we got into Nanopore sequencing! We are always interested in sequencing and assembling genomes from all critters big and small. We're part of a large group working on sequencing all of the species in the Drosophila species group, and we're interested in all types of genome assembly projects.

Long-read RNA sequencing

Sequencing of native RNA is just cool. We do RNA sequencing of our unsolved clinical cases and are interested in using long reads to identify tissue-specific isoforms and expression. Also, what are all those RNA modifications doing? Sequencing of native RNA from different tissues is going to be interesting.

Sequencing Services


The Miller Lab operates the University of Washington Nanopore Sequencing Core, which provides long-read sequencing on the Oxford Nanopore Technologies (ONT) platform to researchers at UW, SCH, SCRI, FHCC, external institutions, and private companies. Services include whole-genome sequencing, RNA sequencing, variant calling and phasing, and methylation calling. If you are interested in long-read sequencing services, please visit the UW Nanopore Sequencing Core site for more information about sample preparation, options, and costs.





Research in the Miller Lab is a healthy mix of computational and bench science. We believe that training the next generation of scientists – at all levels – is one of our most important responsibilities. While we value hard work, we also know work–life balance matters, so if you'd like to be part of a respectful, collaborative, and productive team, we'd love to hear from you! Feel free to email with any inquiries. email

Postdoctoral Researcher

We're currently recruiting for a postdoc position. To apply, please provide a current CV, a summary of your research accomplishments/goals/interests, and contact info for at least three references. Ideal candidates will have programming knowledge as well as wet lab experience and an interest in long-read sequencing. Click here for more information.



We are so very grateful for the generous support our research program receives from the following programs:

BBI logo

NIH logo

NIH EIA logo

  • Sanford Health
    Sanford Children’s Genomic Medicine Consortium Grant
    Jan 2024–Dec 2025 (Co-PI)
  • Kuni Foundation
    Imagination Grant
    Jan 2024–Dec 2025 (Co-PI)
  • University of Washington Department of Laboratory Medicine & Pathology
    Building Bridges Award
    July 2023–July 2024 (Co-PI)
  • National Institutes of Health
    TopMed (R01 HL165061)
    June 2023–May 2027 (Co-PI)
  • National Institutes of Health
    NIH Director’s Early Independence Award (DP5 OD033357-01)
    Sept 2022–Aug 2027 (PI)
  • Seattle Children's Hospital
    Academic Enrichment Fund
    Jan 2022–Aug 2024 (Co-PI)
  • Brotman Baty Institute for Precision Medicine
    Establishment of a long-read sequencing cost center
    2021–2024 (PI)
  • Brotman Baty Institute for Precision Medicine
    Catalytic Collaborations Award
    2022–2024 (Co-PI)
  • Brotman Baty Institute for Precision Medicine
    Catalytic Collaborations Award
    2021–2022 (PI)
  • Brotman Baty Institute for Precision Medicine
    Catalytic Collaborations Award
    2020–2021 (Co-PI)

We appreciate your interest in our research. If you would like to make a contribution to a Miller Lab study, please write a brief letter designating the funds to research by Danny E. Miller, MD, PhD, and indicate the study topic you wish to support. Include your name and address in the letter, and send it with a check or money order to:

Miller Laboratory, Department of Pediatrics
University of Washington
1959 NE Pacific Street, Box 356320
Seattle, WA 98195-6320